Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet
Study Title
- A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet
Teva Identifier
- C33237/1106
ClinicalTrials.gov Identifier
- NCT01758978
Study Status
- Completed
Trial Condition(s)
- Pain
Interventions
- Drug: a 60 mg dose of the hydrocodone bitartrate extended-release tablet administered as either two 30-mg tablets (Treatment A) or one 60-mg tablet (Treatment B).
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 45 Years
Trial Duration
- 12/01/2012 - 01/01/2013
Phase
- Phase 1
Study Type
Interventional
